Measuring Dietary Iron Absorption From Edible Insects and Assessing the Effect of Chitin Content on Iron Bioavailability (Study 2)
NCT ID: NCT05328141
Last Updated: 2022-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
11 participants
INTERVENTIONAL
2022-05-20
2022-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To differentiate iron absorption from insect biomass from other sources, insects will be intrinsically labelled with the stable iron isotope 57Fe, while other food iron components will be labelled with the iron isotope 58Fe.The present studiy will provide novel data to elucidate the nutritional value as sources of dietary iron of insect species Xylotrupes gideon. X. gideon is an insect species traditionally widely consumed in SubSaharan Africa and South East Asia and recognised by FAO as an edible insect species. X gideon is produced in ZHAW facilities in Linthal, Switzerland under controlled conditions aiming to a highly sustainable and high nutritional value food product. Furthermore the benefit of ascorbic acid addition to X.gideon biomass on iron absorption will be quantified.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Bean Polyphenols and Phytic Acid on Iron Absorption
NCT01472484
Perceived Satiety and Consumer Sensory Acceptance of Functional Foods Enriched With Edible Insect and Plant Proteins
NCT07181408
The Effects of Rye Crisp Bread on Appetite and Metabolic Function
NCT02011217
Zinc Absorption in Flakes Derived from Sprouted or Hydrothermally Processed Wheat
NCT06236620
Non-heme Iron Absorption From Single Meals of Fava Bean Protein, Beef Protein and Cod Protein
NCT05392816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bread and butter
A toast bread with butter meal without insect biomass with FeSO4 (isotopic iron 54)
Bread and butter
A bread with butter meal without insect biomass with FeSO4 (isotopic iron 54)
X.gideon
Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58)
X.gideon
Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58)
X.gideon with ascorbic acid
Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58) and ascorbic acid
X.gideon with ascorbic acid
Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58) and ascorbic acid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bread and butter
A bread with butter meal without insect biomass with FeSO4 (isotopic iron 54)
X.gideon
Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58)
X.gideon with ascorbic acid
Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58) and ascorbic acid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal Body Mass Index (18.5 - 25 kg/m2)
* Body weight ≤ 55 kg
* Non-anemic (hemoglobin (Hb) \>12.0 g/dL)
* Serum Ferritin \< 25 μg/L;
* Normal CRP (\<5.0 mg/L), indicating no inflammation
* Knowledge of English at least at level B2 (assessed by self-declaration)
* Signed informed consent
Exclusion Criteria
* Lactating up to 6 weeks before study initiation
* Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement)
* Continuous/long-term use of medication (except for oral contraceptives and anti-acne medication)
* Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal administration
* Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months
* Earlier participation in a study using iron stable isotopes or participation in any clinical study within the last 30 days
* Participant who cannot be expected to comply with study protocol (e.g. not available on certain study appointments
* Cigarette smoking ( \> 1 cigarette per day)
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zurich University of Applied Sciences
OTHER
Swiss Federal Institute of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nikolin Hilaj, MSc
Role: PRINCIPAL_INVESTIGATOR
Laboratory of Human Nutrition ETH Zürich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ETH Zurich, Laboratory of Human Nutrition
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sust-iron-able2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.